彭挺生医生

熟练掌握各个系统常规标本、冰冻标本病理诊断技术，专长于淋巴造血系统肿瘤和骨髓病理诊断研究方向：骨肉瘤发生发展以及侵袭转移机制的研究 主要教育和工作经历：1994年毕业于河南医科大学临床医疗系获医学学士；1998年毕业于中山医科大学基础医学院病理学专业获医学硕士；2004年毕业于中山大学病理学与病理生理学专业获医学博士；1998年至2006年任中山医科大学中山医院病理学教研/附属第一医院病理科助教、讲师；2007年至2014年任中山大学附属第一医院病理科副教授；2009年至2011年在美国德克萨斯大学MDAndersonCancerCenter从事博士后研究工作两年；2015年起任中山大学附属第一医院病理科主任医师。2007年起聘为硕士研究生导师。社会兼职：现任广东省医学会病理学分会第十届委员会常务委员；中国抗癌协会肿瘤病理专业委员会青年委员会委员；广东省抗癌协会肿瘤病理专业委员会委员；广东省医疗行业协会病理医学管理分会委员论著：共发表论文40余篇，已发表SCI论文20篇。主持国自然、教育部留学回国人员基金、省自然等科研基金项目5项，作为主要参与人参与科研基金7项。主编或参编《病理学》教材/专著8部。SCI论文：1.TianR,XieX,HanJ,LuoC,YongB,PengH,ShenJ,PengT.miR-199a-3pnegativelyregulatestheprogressionofosteosarcomathroughtargetingAXLAmericanJournalofCancerResearch.2014;4(6):738-750.2.HanJ,TianR,YongB,LuoC,TanP,ShenJ,PengT.Gas6/Axlmediatestumorcellapoptosis,migrationandinvasionandpredictstheclinicaloutcomeofosteosarcomapatients.BiochemBiophysResCommun.2013Jun7;435(3):493-500.3.HanJ,YongB,LuoC,TanP,PengT,ShenJ.HighserumalkalinephosphatasecooperatingwithMMP-9predictsmetastasisandpoorprognosisinpatientswithprimaryosteosarcomainSouthernChina.WorldJSurgOncol.2012Feb15;10:37.4.CaoQ,HuangY,YeZ,LiuN,LiS,PengT.PrimaryspleenextranodalNK/Tcelllymphoma,nasaltype,withbonemarrowinvolvementandCD30positiveexpression:acasereportandliteraturereview.DiagnPathol.2014Sep3;9(1):169.5.ShiH,HanJ,LiuN,YeZ,LiZ,LiZ,PengT.Agangliocyticpatiallyglandularparagangliomawithlymphnodemetastasis.DiagnPathol.2014Mar20;9:63.6.XuQ,CaoQ,LiuN,FangZ,YeZ,PengT.Renalcollectingductcarcinomawithextensivecoagulativenecrosismimickinganemicinfarct:reportofacaseandtheliteraturereview.DiagnPathol.2013Jul16;8(1):119.7.PengT,ZhangP,LiuJ,NguyenT,BolshakovS,BelousovR,YoungED,WangX,BrewerK,López-TerradaDH,OliveiraAM,LazarAJ,LevD.Anexperimentalmodelforthestudyofwell-differentiatedanddedifferentiatedliposarcoma;deregulationoftargetabletyrosinekinasereceptors.LabInvest.2011Mar;91(3):392-403.8.ZhangY,YoungED,BillK,BelousovR,PengT,LazarAJ,PollockRE,SimmonsPJ,LevD,KoloninMG.Heterogeneityandimmunophenotypicplasticityofmalignantcellsinhumanliposarcomas.StemCellRes.2013Sep;11(2):772-81.9.HoffmanA,GhadimiMP,DemiccoEG,CreightonCJ,TorresK,ColomboC,PengT,LusbyK,IngramD,HornickJL,WangWL,RaviV,LazarAJ,LevD,PollockRE.Localizedandmetastaticmyxoid/roundcellliposarcoma:clinicalandmolecularobservations.Cancer.2013May15;119(10):1868-77.10.TanP,ZouC,YongB,HanJ,ZhangL,SuQ,YinJ,WangJ,HuangG,PengT,ShenJ.ExpressionandprognosticrelevanceofPRAMEinprimaryosteosarcoma.BiochemBiophysResCommun.2012Mar23;419(4):801-8.11.ZhangP,BillK,LiuJ,YoungE,PengT,BolshakovS,HoffmanA,SongY,DemiccoEG,TerradaDL,CreightonCJ,AndersonML,LazarAJ,CalinGG,PollockRE,LevD.MiR-155isaliposarcomaoncogenethattargetscaseinkinase-1αandenhancesβ-cateninsignaling.CancerRes.2012Apr1;72(7):1751-62.12.DemiccoEG,TorresKE,GhadimiMP,ColomboC,BolshakovS,HoffmanA,PengT,BovéeJV,WangWL,LevD,LazarAJ.InvolvementofthePI3K/Aktpathwayinmyxoid/roundcellliposarcoma.ModPathol.2012Feb;25(2):212-21.13.XieX,GhadimiMP,YoungED,BelousovR,ZhuQS,LiuJ,LopezG,ColomboC,PengT,ReynosoD,HornickJL,LazarAJ,LevD.CombiningEGFRandmTORblockadeforthetreatmentofepithelioidsarcoma.ClinCancerRes.2011Sep15;17(18):5901-12.14.GhadimiMP,Al-ZaidT,MadewellJ,PengT,ColomboC,HoffmanA,CreightonCJ,ZhangY,ZhangA,LazarAJ,PollockRE,LevD.Diagnosis,management,andoutcomeofpatientswithdedifferentiatedliposarcomasystemicmetastasis.AnnSurgOncol.2011Dec;18(13):3762-70.15.GhadimiMP,LiuP,PengT,BolshakovS,YoungED,TorresKE,ColomboC,HoffmanA,BroccoliD,HornickJL,LazarAJ,PistersP,PollockRE,LevD.Pleomorphicliposarcoma:clinicalobservationsandmolecularvariables.Cancer.2011Dec1;117(23):5359-69.16.YeZ,ShiH,PengT,HanA.Clinicalandpathologicalfeaturesofhighgradeprimarycardiacosteosarcoma.InteractCardiovascThoracSurg.2011Jan;12(1):94-5.17.WangA,LiuX,ShengS,YeH,PengT,ShiF,CroweDL,ZhouX.Dysregulationofheatshockprotein27expressioninoraltonguesquamouscellcarcinoma.BMCCancer.2009Jun4;9:167.18.YeH,WangA,LeeBS,YuT,ShengS,PengT,HuS,CroweDL,ZhouX.Proteomicbasedidentificationofmanganesesuperoxidedismutase2(SOD2)asametastasismarkerfororalsquamouscellcarcinoma.CancerGenomicsProteomics.2008Mar-Apr;5(2):85-94.19.WangL,LiHG,WenJM,PengTS,ZengH,WangLY.ExpressionofCD44v3,erythropoietinandVEGF-Cingastricadenocarcinomas:correlationswithclinicopathologicalfeatures.Tumori.2014May-Jun;100(3):321-32720.WangL,LiHG,XiaZS,LüJ,PengTS.IMP3isanovelbiomarkertopredictmetastasisandprognosisofgastricadenocarcinoma:aretrospectivestudy.ChinMedJ(Engl).2010Dec;123(24):3554-8.